Fortified Bread
OtherIntervention group will be supplied with fortified bread delivering >20 μg vitamin D3 in a daily portion and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
NCT Number: NCT07481240
Vitamin D deficiency is common. It is caused by limited sun availability together with a low supply of vitamin D in the food system. There is a high prevalence of low vitamin D status around the world. In Ireland, our relatively northern latitude and prevailing weather mean that UVB availability for skin synthesis of vitamin D is limited in this country and our population relies on the dietary supply of vitamin D to prevent deficiency. Thus, the endemic Irish problem of vitamin D malnutrition is due to the lack of vitamin D in our food system. Dietary guidelines cannot address this issue because foods naturally rich in vitamin D are very few and infrequently consumed.
The FamDBread study will test the hypothesis that a vitamin D-fortified bread as part of a healthy diet that includes vitamin D-fortified foods is effective in preventing low vitamin D status during winter, and safe for families to consume.
Looking for future studies?
Notify Me5 year–59 year
All sexes
Interventional
Not applicable
Human Nutrition Studies Unit, School of Food and Nutritional Sciences, Cork, Co. Cork, Ireland
This randomised controlled dietary intervention study aims to recruit households/families of children, teens and adults, with 128 participants who will be randomised to receive vitamin D-fortified bread and advice to consume additional commercially available fortified foods (Treatment group) or identical unfortified bread and advice to consume additional commercially available fortified foods (Control group). The outcome of the study is to test whether increasing vitamin D intake through food (Treatment group) is sufficient to prevent wintertime vitamin D deficiency (measured using serum concentrations of 25-hydroxyvitamin D <30 nmol/L) in comparison with the Control group.
The target vitamin D intake for the treatment group in this study is >20 μg/ day vitamin D. This will maintain serum concentrations of 25-hydroxyvitamin D (25(OH)D) (the biomarker of vitamin D status) > 30 nmol/L, the clinical deficiency threshold to prevent metabolic bone disease, in over 90% of participants. At this vitamin D intake level, about 80% of participants will have a 25(OH)D concentration > 50 nmol/L, the personal intake target in the US and EU.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention group will be supplied with fortified bread delivering >20 μg vitamin D3 in a daily portion and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Placebo control group will be supplied with unfortified bread and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Time frame: 8 weeks
Comparison of the number of participants with low vitamin D status (e.g. <30 nmol/L and < 50 nmol/L serum 25(OH)D) between treatment and placebo groups
Time frame: 8 weeks
Comparison of prevalence of inadequate vitamin D intakes relative to North American and European dietary recommendations
Time frame: 8 weeks
Comparison of albumin-corrected serum calcium concentrations < 2.6 mmol/L between treatment and placebo control groups
Time frame: 8 weeks
Comparison of circulating biomarkers of metabolic health status and metabolomic markers between active and placebo groups
University College Cork
Other
Fam-D-Bread: A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families
Acronym: Fam-D-Bread
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT06700122
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT06654063
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT06203041
Avitaminosis, Behavior
Rochester, Minnesota, United States
View Trial Details